Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Fortrea helps its biotech and pharmaceutical customers run clinical trials with the goal of winning approval to sell new treatments in the U.S. and other countries. Fortrea helps design...
— Christian Ryther
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Fortrea Holdings Inc.
Spun off from Labcorp in 2023, the clinical trial provider is working through a business turnaround. Its current stock...
Fortrea helps its biotech and pharmaceutical customers to run clinical trials with the goal of receiving marketing authorization in the U.S. and other countries.
Fortrea helps its biotech and pharmaceutical customers to run clinical trials with the goal of receiving marketing authorization in the U.S. and other countries. For...
More institutional theses from Curreen Capital
Advance Auto Parts is a retailer of replacement automotive parts and supplies. These include batteries,...
We also sold Siemens Energy (receiving €143.44 per share) and Computacenter (receiving £57.28 per share). Both stocks had...
Frontdoor sells home service plans to homeowners. )....